Long-acting technologies for infectious diseases in LMICs

Lancet. 2018 Nov 3;392(10158):1610-1611. doi: 10.1016/S0140-6736(18)32544-3. Epub 2018 Oct 24.

Authors

Lelio Marmora¹, Carmen Pérez Casas², Ian Grubb³, Craig McClure³

Affiliations

¹ Unitaid, Geneva 1218, Switzerland.
² Unitaid, Geneva 1218, Switzerland. Electronic address: [email protected].
³ Health Hounds Inc, Toronto, ON, Canada.

PMID: 30497794
DOI: 10.1016/S0140-6736(18)32544-3

No abstract available

MeSH terms

Communicable Disease Control*
Communicable Diseases / therapy*
Delayed-Action Preparations / administration & dosage*
Delivery of Health Care / standards
Developing Countries
Global Health
Humans

Substances

Delayed-Action Preparations